Synthesis, bioactivation and anti-HIV activity of the bis(4-acyloxybenzyl) and mono(4-acyloxybenzyl) esters of the 5′-monophosphate of AZT
- 1 January 1993
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Journal of the Chemical Society, Perkin Transactions 1
- No. 11,p. 1239-1245
- https://doi.org/10.1039/p19930001239
Abstract
To investigate the design of prodrugs of antiviral nucleosides for targeting to the central nervous system, the bis(4-acyloxybenzyl) esters of the 5′-monophosphate of AZT 5(R = Me, Et, Pri or But) have been prepared. The reaction of the appropriate bis(4-acyloxybenzyl)N,N-diisopropylphosphoramidite 10(R = Me, Et, Pri or But) with AZT in the presence of 1H-tetrazole, followed by oxidation of the PIII intermediate with 3-chlcroperoxybenzoic acid gave the required triesters 5 in good yield. The lithium salts of the mono (4-acyloxybenzyl) esters of the 5′-phosphate of AZT 7(R = Me, Et, Pri or But) were prepared by treatment of the triesters 5 with lithium iodide. In the presence of porcine liver carboxyesterase the triesters 5 and diesters 7 decomposed readily to the 5′-monophosphate of AZT 9. The anti-HIV activities of the triesters 5 and diesters 7 were, with one exception, comparable to that of AZT, but the greater cytotoxicity of certain compounds in particular types of cell significantly reduced their selectivity indices.Keywords
This publication has 37 references indexed in Scilit:
- Synthesis and in vitro evaluation of a phosphonate prodrug: bis(pivaloyloxymethyl) 9-(2-phosphonylmethoxyethyl)adenineAntiviral Research, 1992
- Bioreversible protection for the phospho group: bioactivation of the di(4-acyloxybenzyl) and mono(4-acyloxybenzyl) phosphoesters of methylphosphonate and phosphonoacetateJournal of the Chemical Society, Perkin Transactions 1, 1992
- Bioreversible protection for the phospho group: chemical stability and bioactivation of di(4-acetoxybenzyl) methylphosphonate with carboxyesteraseJournal of the Chemical Society, Chemical Communications, 1991
- Hybrid Pharmacokinetic Models to Describe Anti-HIV Nucleoside Brain Disposition Following Parent and Prodrug Administration in MicePharmaceutical Research, 1991
- Central Nervous System Effects of Human Immunodeficiency Virus Type 1Annual Review of Medicine, 1990
- Synthesis of acyloxyalkyl acylphosphonates as potential prodrugs of the antiviral, trisodium phosphonoformate (foscarnet sodium)Tetrahedron Letters, 1989
- Chapter 31. Strategies for Delivery of Drugs Through the Blood-Brain BarrierPublished by Elsevier ,1985
- Bioreversible phosphate protective groups: Synthesis and stability of model acyloxymethyl phosphatesBioorganic Chemistry, 1984
- Biologically Reversible Phosphate-Protective GroupsJournal of Pharmaceutical Sciences, 1983
- Kinetics of the Hydrolysis of Phosphate EstersRussian Chemical Reviews, 1977